Sustained release of lipophilic gemcitabine from an injectable polymeric hydrogel for synergistically enhancing tumor chemoradiotherapy
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Abstract Gemcitabine (Gem), an analogue of deoxycytidine, has potent antitumor activities against various solid tumors and is an excellent radiosensitizer as well. However, Gem has a very short half-life, making it difficult to achieve the long-term synergies between chemotherapy and radiotherapy. Herein, we developed a long-acting Gem delivery system using a palmityl modified Gem derivative (GemC16) as the drug and an injectable and thermosensitive hydrogel as the vehicle, and then combined with multiple radiation therapy for the synergistic treatment of tumors. The thermosensitive hydrogel that exhibited a temperature-responsive sol–gel transition was composed of two poly(D,L-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(D,L-lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) triblock copolymers with different PLGA/PEG ratios. Such a physical hydrogel formed an internal structure of percolated micelle network, in which the polymeric micelles played a reservoir role in effectively solubilizing lipophilic GemC16 in water. In vitro tests manifested that the entrapped GemC16 was, in the form of micelles and micellar aggregates, released out of the hydrogel depot in a sustained pattern for over one month. In vitro cellular assays demonstrated that GemC16 mediated by the polymeric micelles was rapidly internalized to tumor cells via endocytosis. After a single peritumoral administration of the hydrogel system combined with local multiple X ray exposures, the sustained release of GemC16 exerted a long-acting chemotherapy effect and afforded a durable radiosensitization, thereby synergistically enhancing chemoradiotherapy efficacy, inhibiting metastasis and ameliorating complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Opportunities and challenges of radiotherapy for treating cancer
Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784
Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
Moysan, E., Bastiat, G., & Benoit, J.-P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300370t · Cited by 225
Shen, W., Chen, X., Luan, J., Wang, D., Yu, L., & Ding, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11998 · Cited by 138
Self-citation
Cited by
PEG-based thermosensitive and biodegradable hydrogels
Shi, J., Yu, L., & Ding, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.009 · Cited by 341
Self-citationRecent advances in regenerative biomaterials
Cao, D., & Ding, J. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac098 · Cited by 259
Self-citationRecent advances in long-acting drug delivery systems for anticancer drug
Pacheco, C., Baião, A., Ding, T., Cui, W., & Sarmento, B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114724 · Cited by 190
Gu, W., Fan, R., Quan, J., Cheng, Y., Wang, S., Zhang, H., Zheng, A., & Song, S. (2022) · Polymers · doi:10.3390/polym14163368 · Cited by 25
Nanomaterials Based on Functional Polymers for Sensitizing Cancer Radiotherapy
Lin, J., Yin, M., Liu, X., Meng, F., & Luo, L. (2022) · Macromolecular Rapid Communications · doi:10.1002/marc.202200194 · Cited by 18
Liu, J., Zhao, L., Sun, Y., Fu, Q., & Xiao, W. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102186 · Cited by 9
“Reproduced with permission [74].”
Metadata
- Authors
- Yang, X., Chen, X., Wang, Y., Xu, G., Yu, L., & Ding, J.
- Venue
- Chemical Engineering Journal
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 396
- Pages
- 125320
- ISSN
- 1385-8947 (ISSN-L)
- OpenAlex
- W3023511370
- Cited by
- 76
- References
- 4
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.